“Pathologic Complete Response After Preoperative Ipilimumab and Nivolumab in an HLRCC Patient With Stage III RenalCell Carcinoma”. Journal of Kidney Cancer 13, no. 2 (June 1, 2026): 21–28. Accessed June 4, 2026. https://www.jkcvhl.com/index.php/jkcvhl/article/view/455.